TİGEN, M. K. Et Al. 2017. Bleeding risk with concomitant use of tiro ban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction. 33nd Turkish Cardiology Congress With International Participation .

TİGEN, M. K., ÖZDİL, M. H., ÇİNÇİN, A. A., KANAR, B., GÜREL, E., SÜNBÜL, M., ... KOL, A.(2017). Bleeding risk with concomitant use of tiro ban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction . 33nd Turkish Cardiology Congress With International Participation

TİGEN, MUSTAFA Et Al. "Bleeding risk with concomitant use of tiro ban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction," 33nd Turkish Cardiology Congress With International Participation, 2017

TİGEN, MUSTAFA K. Et Al. "Bleeding risk with concomitant use of tiro ban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction." 33nd Turkish Cardiology Congress With International Participation , 2017

TİGEN, M. K. Et Al. (2017) . "Bleeding risk with concomitant use of tiro ban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction." 33nd Turkish Cardiology Congress With International Participation .

@conferencepaper{conferencepaper, author={MUSTAFA KÜRŞAT TİGEN Et Al. }, title={Bleeding risk with concomitant use of tiro ban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction}, congress name={33nd Turkish Cardiology Congress With International Participation}, city={}, country={}, year={2017}}